Sex-based discrimination in medicine costs lives | Letters

Readers respond to an article on women being less likely than men to be offered active treatment for the same conditions As head of pharmacovigilance at a clinical trials technology company, I was not surprised that a review of global research found that women are less likely than men to be offered active treatment for the same conditions ( Women with same health conditions as men ‘less likely to be offered active treatment’, 16 September ).

This inequality costs lives. A British Heart Foundation-funded study found that women were less…